All Roll Calls
Yes: 214 • No: 42
Sponsored By: Cecilia Aguiar-Curry (Democratic)
Signed by Governor
Personalized for You
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
8 provisions identified: 7 benefits, 0 costs, 1 mixed.
Health plans and insurers that cover prescriptions must cover mifepristone (brand or generic) for medication abortion. They cannot deny it just because the use differs from FDA labeling or REMS, unless the state finds an imminent safety risk. Plans must also cover mifepristone for abortion if major health bodies (like WHO or the National Academies) or the state recognize it, even without FDA approval. Off-label drugs for life‑threatening or chronic, seriously debilitating conditions are covered when recognized by key medical compendia or by strong peer‑reviewed studies. Coverage includes medically necessary services tied to giving the drug, and you can seek review if a denial is based on being “experimental.”
Pharmacists can dispense mifepristone without printing names or the pharmacy address on the container, using a prescription number instead. Pharmacies must keep a private log linking the number to the full prescription and tell the patient about this. Police cannot see that log without a valid court subpoena. The state can add or remove medication‑abortion drugs from certain labeling rules and generally exempts them if WHO recommends the drug and its label was accurate at manufacture, unless there is an imminent safety concern. A technical timing rule ties which pharmacist labeling version applies to whether another bill (AB 1503) takes effect before January 1, 2026.
Health plans and insurers cannot fire, drop, or penalize a provider just because that provider faced out‑of‑state cases or discipline based only on laws that block care legal in California. They also cannot punish providers for lawful mifepristone‑related activities in California. This protection does not apply if the conduct would also be grounds for action under California law. The Insurance Commissioner can enforce these rules against insurers.
The law bars civil, criminal, and licensing actions against California health professionals solely for lawful acts with mifepristone or other medication‑abortion drugs. This covers prescribing, administering, manufacturing, transporting, distributing, delivering, acquiring, possessing, furnishing, dispensing, repackaging, and storage. Boards and departments cannot suspend, revoke, or deny a license just for those lawful acts, and cannot rely on out‑of‑state convictions that would not be grounds in California. The state may still act when needed to address an imminent health or safety concern.
Medical records that identify someone and relate to getting or helping with a lawful abortion in California generally cannot be sent to out‑of‑state people or agencies. Limited exceptions apply, such as patient authorization, payment duties, accreditation or quality review, approved research, disclosures to the patient, or court orders with protections. Providers who work in good faith to follow this law have a safe harbor until January 31, 2027.
State prisons, local jails, and juvenile facilities cannot add extra limits beyond California law to stop someone from getting a legal abortion. A person who is pregnant can be checked for eligibility and, if eligible and after informed consent, get the abortion. Facilities must post these rights where people can see them.
A minor can agree to medical care to prevent or treat pregnancy without a parent’s permission. Sterilization of a minor still requires consent from a parent or guardian.
The law repeals Penal Code Section 1108 and Business and Professions Code Section 601. These sections are removed from state law; no new fees or benefits are set in their place.
Cecilia Aguiar-Curry
Democratic • House
Rebecca Bauer-Kahan
Democratic • House
Marc Berman
Democratic • House
Jessica Caloza
Democratic • House
Sabrina Cervantes
Democratic • Senate
Robert Garcia
Democratic • House
Mark Mark González
Democratic • House
Maggy Krell
Democratic • House
Monique Limón
Democratic • Senate
Liz Ortega
Democratic • House
Diane Papan
Democratic • House
Darshana R. Patel
Democratic • House
Darshana R. Patel
Democratic • House
Gail Pellerin
Democratic • House
Cottie Petrie-Norris
Democratic • House
Sharon Quirk-Silva
Democratic • House
Susan Rubio
Democratic • Senate
Catherine Stefani
Democratic • House
Aisha Wahab
Democratic • Senate
Akilah Weber Pierson
Democratic • Senate
Anamarie Ãvila FarÃas
Democratic • House
All Roll Calls
Yes: 214 • No: 42
House vote • 9/10/2025
Item 203 — Assembly AFLOOR
Yes: 61 • No: 12
Senate vote • 9/9/2025
Item 279 — Senate SFLOOR
Yes: 30 • No: 8
legislature vote • 8/29/2025
Vote in CS61
Yes: 5 • No: 2
legislature vote • 7/7/2025
Vote in CS61
Yes: 6 • No: 0
legislature vote • 6/23/2025
Vote in CS42
Yes: 8 • No: 2
legislature vote • 6/11/2025
Vote in CS60
Yes: 6 • No: 1
House vote • 5/19/2025
Item 58 — Assembly AFLOOR
Yes: 61 • No: 11
legislature vote • 5/14/2025
Vote in CX25
Yes: 11 • No: 4
legislature vote • 4/29/2025
Vote in CX33
Yes: 14 • No: 1
legislature vote • 4/8/2025
Vote in CX08
Yes: 12 • No: 1
Chaptered by Secretary of State - Chapter 136, Statutes of 2025.
Approved by the Governor.
Enrolled and presented to the Governor at 3 p.m.
Urgency clause adopted. Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 61. Noes 12. Page 3193.).
In Assembly. Concurrence in Senate amendments pending.
Read third time. Urgency clause adopted. Passed. Ordered to the Assembly. (Ayes 30. Noes 8. Page 2736.).
Read second time. Ordered to third reading.
Read third time and amended. Ordered to second reading.
Read second time. Ordered to third reading.
From committee: Do pass. (Ayes 5. Noes 2.) (August 29).
In committee: Referred to APPR. suspense file.
From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 2.) (June 23). Re-referred to Com. on APPR.
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.
Read second time and amended. Re-referred to Com. on B. P. & E.D.
From committee: Amend, and do pass as amended and re-refer to Com. on B. P. & E.D. (Ayes 6. Noes 1.) (June 11).
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.
Referred to Coms. on HEALTH and B. P. & E.D.
In Senate. Read first time. To Com. on RLS. for assignment.
Read third time. Passed. Ordered to the Senate. (Ayes 61. Noes 11. Page 1601.)
Read second time. Ordered to third reading.
From committee: Do pass. (Ayes 11. Noes 4.) (May 14).
From committee: Do pass and re-refer to Com. on APPR. (Ayes 14. Noes 1.) (April 29). Re-referred to Com. on APPR.
Coauthors revised.
Coauthors revised.
From committee: Do pass and re-refer to Com. on B. & P. (Ayes 12. Noes 1.) (April 8). Re-referred to Com. on B. & P.
Chaptered
9/26/2025
Enrolled
9/12/2025
Amended Senate
9/5/2025
Amended Senate
6/18/2025
Amended Senate
6/13/2025
Amended Senate
6/2/2025
Amended Assembly
3/17/2025
Introduced
1/16/2025